A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TBC / thiotepa, busulfan, and cyclophosphamide

[Related PubMed/MEDLINE]
Total Number of Papers: 14
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TBC  (>> Co-occurring Abbreviation)
Long Form:   thiotepa, busulfan, and cyclophosphamide
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Thiotepa, busulfan, and cyclophosphamide or busulfan, cyclophosphamide, and etoposide high-dose chemotherapy followed by autologous stem cell transplantation for consolidation of primary central nervous system lymphoma. ASCT, BuCyE, OS, PCNSL, PFS
2017 A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning. ASCT, OS, PCNSL, PFS, PK, SCNSL, TRM
2017 High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission. HDC-ASCT, PCNSL
2016 Treatment of patients with secondary central nervous system lymphoma with high-dose busulfan/thiotepa-based conditioning and autologous stem cell transplant. ASCT, HD, R-BuMelTt, SCNSL
2015 Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide. ASCT, CNS, HDC, OS, PFS
2015 Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma. ASCT, CNS, CR, NHL, R-TBC
2012 Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma. ASCT, CI, MRI, NHL, PCNSL, PFS, SCNSL
2012 Upfront thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation for primary CNS lymphoma: a single centre experience. ASCT, KPS, PCNSL, WBRT
2004 Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma. ASCT, CR, HDC, HDM, OS, PFS, PR
10  2003 High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma. ASCT, CR, HD-MTX, KPS, PCNSL, WBRT
11  2001 Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia. AML, MDS, TRM
12  2001 Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma. CR, MM, PBSC
13  1999 Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia. CML, VOD
14  1996 Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies. BMT, DFS